Pro Share Advisors LLC Biomarin Pharmaceutical Inc Transaction History

Pro Share Advisors LLC

  • $36.7 Billion
  • Q1 2024

A detailed history of Pro Share Advisors LLC transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Pro Share Advisors LLC holds 13,221 shares of BMRN stock, worth $1.09 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
13,221
Previous 12,036 9.85%
Holding current value
$1.09 Million
Previous $1.16 Million 0.52%
% of portfolio
0.0%
Previous 0.0%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 08, 2024
BUY
$83.81 - $99.0 $99,314 - $117,315
1,185 Added 9.85%
13,221 $1.15 Million
Q4 2023

Feb 14, 2024
SELL
$76.22 - $98.51 $20,274 - $26,203
-266 Reduced 2.16%
12,036 $1.16 Million
Q3 2023

Nov 13, 2023
BUY
$85.07 - $94.48 $13,355 - $14,833
157 Added 1.29%
12,302 $1.09 Million
Q2 2023

Aug 10, 2023
SELL
$86.68 - $100.3 $68,217 - $78,936
-787 Reduced 6.09%
12,145 $1.05 Million
Q1 2023

May 11, 2023
SELL
$87.74 - $117.27 $461,336 - $616,605
-5,258 Reduced 28.91%
12,932 $1.26 Million
Q4 2022

Feb 02, 2023
SELL
$80.93 - $108.63 $29,620 - $39,758
-366 Reduced 1.97%
18,190 $1.88 Million
Q3 2022

Nov 04, 2022
BUY
$82.16 - $96.94 $91,937 - $108,475
1,119 Added 6.42%
18,556 $1.57 Million
Q2 2022

Aug 01, 2022
SELL
$71.48 - $86.85 $415,084 - $504,337
-5,807 Reduced 24.98%
17,437 $1.45 Million
Q1 2022

May 10, 2022
SELL
$74.28 - $92.69 $536,747 - $669,777
-7,226 Reduced 23.72%
23,244 $1.79 Million
Q4 2021

Feb 08, 2022
SELL
$71.72 - $91.47 $935,515 - $1.19 Million
-13,044 Reduced 29.98%
30,470 $2.69 Million
Q3 2021

Nov 12, 2021
BUY
$74.77 - $85.47 $303,940 - $347,435
4,065 Added 10.3%
43,514 $3.36 Million
Q2 2021

Aug 13, 2021
BUY
$75.51 - $84.79 $820,491 - $921,328
10,866 Added 38.02%
39,449 $3.29 Million
Q1 2021

May 14, 2021
SELL
$74.73 - $90.69 $201,771 - $244,863
-2,700 Reduced 8.63%
28,583 $2.16 Million
Q4 2020

Feb 09, 2021
SELL
$72.61 - $90.2 $9.27 Million - $11.5 Million
-127,661 Reduced 80.32%
31,283 $2.74 Million
Q3 2020

Nov 13, 2020
BUY
$71.87 - $131.03 $1.66 Million - $3.02 Million
23,073 Added 16.98%
158,944 $12.1 Million
Q2 2020

Aug 03, 2020
BUY
$79.55 - $124.22 $1.52 Million - $2.37 Million
19,113 Added 16.37%
135,871 $16.8 Million
Q1 2020

May 15, 2020
SELL
$71.37 - $96.85 $3.22 Million - $4.38 Million
-45,177 Reduced 27.9%
116,758 $9.87 Million
Q4 2019

Feb 12, 2020
BUY
$64.27 - $86.37 $243,326 - $326,996
3,786 Added 2.39%
161,935 $13.7 Million
Q3 2019

Nov 12, 2019
BUY
$67.4 - $85.11 $73,398 - $92,684
1,089 Added 0.69%
158,149 $10.7 Million
Q2 2019

Aug 13, 2019
SELL
$80.35 - $93.9 $1.6 Million - $1.86 Million
-19,852 Reduced 11.22%
157,060 $13.5 Million
Q1 2019

May 15, 2019
BUY
$84.2 - $98.62 $180,356 - $211,244
2,142 Added 1.23%
176,912 $15.7 Million
Q4 2018

Feb 14, 2019
BUY
$80.14 - $106.07 $1.41 Million - $1.86 Million
17,544 Added 11.16%
174,770 $14.9 Million
Q3 2018

Nov 14, 2018
SELL
$93.92 - $105.72 $735,111 - $827,470
-7,827 Reduced 4.74%
157,226 $15.2 Million
Q2 2018

Aug 13, 2018
SELL
$76.01 - $99.03 $1.34 Million - $1.74 Million
-17,577 Reduced 9.62%
165,053 $15.5 Million
Q1 2018

May 14, 2018
BUY
$77.67 - $92.63 $544,466 - $649,336
7,010 Added 3.99%
182,630 $14.8 Million
Q4 2017

Feb 14, 2018
BUY
$80.76 - $95.13 $1.36 Million - $1.6 Million
16,812 Added 10.59%
175,620 $15.7 Million
Q3 2017

Nov 13, 2017
BUY
$80.6 - $94.95 $1.27 Million - $1.49 Million
15,735 Added 11.0%
158,808 $14.8 Million
Q2 2017

Aug 11, 2017
BUY
N/A
143,073
143,073 $13 Million

Others Institutions Holding BMRN

# of Institutions
623
Shares Held
181M
Call Options Held
1.73M
Put Options Held
1.73M
View Full List

About BIOMARIN PHARMACEUTICAL INC

BMRN Quotes by TradingView
  • Ticker BMRN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,824,000
  • Market Cap $15.3B
  • Description
  • BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...
More about BMRN
Track This Portfolio

Track Pro Share Advisors LLC Portfolio

Follow Pro Share Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pro Share Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pro Share Advisors LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email